Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
This intro compares merchant acceptance for BTC and ETH, outlining where each is more commonly accepted by merchants.
27,224 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
A $1 trillion capital-expenditure surge is shaping the investment landscape for 2027. Here are three stocks primed to...
What happens when a director chooses a real puppet over CGI? This finance-focused look at practical effects translate...
A calmer catastrophe year can boost underwriting margins and reserve efficiency. This piece explains why allstate hav...
In the first half of 2026, Vertiv soared as AI data centers pushed demand for cooling and power solutions. This artic...
When the carradine family breaks hollywood, they show how openness can shape finances and future planning. This artic...
At the dawn of 2026, rental demand isn’t following the usual big-city script. Cities like Cincinnati, Atlanta, and Mi...
The White House accelerates its plan to replace lost tariff revenue after a Supreme Court ruling, signaling a long, c...
Spotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
In healthcare robotics, durable moats matter as much as dazzling tech. This article breaks down why intuitive surgica...
In 2026, investors face a crowded field of passive options. This guide breaks down index funds and ETFs, reveals when...
A historic step: Paxos earns SEC clearance to operate as a registered clearing agency. This milestone could reshape c...